# Shenbai Granules for Preventing Malignant Transformation of High-risk Colorectal Adenomas

> **NCT07129499** · NA · NOT_YET_RECRUITING · sponsor: **Jiangsu Famous Medical Technology Co., Ltd.** · enrollment: 450 (estimated)

## Conditions studied

- Colorectal Adenoma
- High Risk
- TCM

## Interventions

- **DRUG:** Shenbai Granules
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07129499
- **Lead sponsor:** Jiangsu Famous Medical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-15
- **Primary completion:** 2028-11-30
- **Final completion:** 2028-11-30
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2025-08-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07129499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07129499, "Shenbai Granules for Preventing Malignant Transformation of High-risk Colorectal Adenomas". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT07129499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*